Some tumors are characterized by the prevalence of a mutation in a specific gene, such as the G-protein coding BRAF in thyroid carcinoma (Kimura et al., 2003) or IDH1, translating into isocitrate dehydrogenase, in low-grade glioma (Yan et al., 2009). This evidence concerns the gene IDH3A and thyroid gland carcinoma.